The stock of GE HealthCare Technologies Inc. (NASDAQ:GEHC) increased by $1.17 on Tuesday to finish at $70.48, up 1.69 percent. The last five days have seen an average of 2,456,400 shares of common stock traded. The average number of shares traded over the last 20 days was 2,659,205, while the average volume over the last 50 days totaled 2,924,726.
GEHC stock dropped -9.64% since last month. On 08/25/23, the company’s shares reached a one-month low of $67.61. The stock touched a high of $87.83, after rallying from a low of $53.00 in 52 weeks. The price of GEHC stock has risen by 20.73% or $12.10 this year, reaching a new high 25 times. Still, the stock price is down -19.75% from the 52-week high.
Insider Transactions
GEHC stock investors should be aware that GE HealthCare Technologies Inc. (GEHC) stock had its last reported insider trading activity 30 days ago on Jul 31. On Jul 31, CEO, PDx O’Neill Kevin Michael sold 15,609 shares at $77.32 each. This transaction resulted in the insider making $1,206,949. On Jun 08, Rott Roland sold 2,473 shares at a price of US$77.37. After the transaction, the insider now owns 22,335 shares. CEO, Imaging Makela Jan had earlier sold 70,629 shares on Mar 14 for $77.69 a share. The transaction was completed for $5,487,379.
Valuation Metrics
GE HealthCare Technologies Inc. (GEHC) has a trailing price-to-earnings (P/E) ratio of 17.54. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.68, the price-to-book (PB) ratio of 4.52, and the price-to-cash flow ratio of 18.80.
Company paid $0.03 per share in dividends, remained unchanged from $0.03 last year.
Financial Health
For the three months ended June 29, GE HealthCare Technologies Inc.’s quick ratio was 0.90, while its current ratio was 1.20, indicating its inability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 1.44, and the total debt to equity ratio is 1.44. As far as profitability goes, gross margin for the trailing twelve months is 39.60% percent. GE HealthCare Technologies Inc.’s EBITDA margin for the year ended June 29 was 17.43%, whereas its operating margin stood at 13.20% for the same period. Based on annual data, it had gross profit of $7.18 billion and revenue of $18.34 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. GEHC’s return on assets (ROA) during the last 12 months has been 6.20%. There was a 11.10% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 18.30%.
Earnings Surprise
According to GE HealthCare Technologies Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $4.02 billion, while revenues rose by 100.0% to $3.93 billion. It was predicted that GE HealthCare Technologies Inc.’s quarterly earnings would be $0.92, but it ended up being $0.87, beating the consensus by 5.70%. EBITDA was $726.0 million for the quarter. At the end of GE HealthCare Technologies Inc.’s most recent quarter ended June 29, its liabilities totaled 25.2 billion, while its total debt was $10.61 billion. Equity owned by shareholders amounts to $454.84 million.
Technical Picture
Here’s a quick look at GE HealthCare Technologies Inc.’s (GEHC) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 45.10%, suggesting the stock is Neutral, with a 21.27% historical volatility rate.
The stochastic %K and %D were 25.68% and 16.71% respectively, while the average true range (ATR) was 1.35. Based on the 14-day stochastic reading of 41.18%, the RSI (14) reading is 38.31%. On the 9-day MACD Oscillator, the stock is at 0.52, and the 14-day reading is at -0.35.
Analyst Ratings
In its analyst report released on August 25, 2023, Argus began covering GE HealthCare Technologies Inc. (NASDAQ: GEHC). The stock was rated as a Buy by the brokerage firm. Analysts have assigned GE HealthCare Technologies Inc. (GEHC) an Overweight rating. GEHC is a stock that is recommended for selling by 1 brokerage firm, while 4 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 7 others recommend it as a buy.
What is GEHC’s price target for the next 12 months?
The current consensus forecast for the stock is between $78.00 and $99.00, with a median target price of $91.00. In analyzing these forecasts, the average price target given by analysts for GE HealthCare Technologies Inc. (GEHC) is $89.90.
